News Feed - US

Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating Compass, EyePoint, F45, and PROG and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. (NYSE: CMP), EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), F45 Training Holdings, Inc....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating Compass, EyePoint, F45, and PROG and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. (NYSE: CMP), EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), F45 Training Holdings, Inc....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating Compass, EyePoint, F45, and PROG and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. (NYSE: CMP), EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), F45 Training Holdings, Inc....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating Compass, EyePoint, F45, and PROG and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. (NYSE: CMP), EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), F45 Training Holdings, Inc....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating FedEx, Opendoor, Sotera, and Cantaloupe and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FedEx Corp. (NYSE: FDX), Opendoor Technologies, Inc. (NASDAQ: OPEN), Sotera Health Company (NASDAQ: SHC), and Cantaloupe,...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating FedEx, Opendoor, Sotera, and Cantaloupe and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FedEx Corp. (NYSE: FDX), Opendoor Technologies, Inc. (NASDAQ: OPEN), Sotera Health Company (NASDAQ: SHC), and Cantaloupe,...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating FedEx, Opendoor, Sotera, and Cantaloupe and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FedEx Corp. (NYSE: FDX), Opendoor Technologies, Inc. (NASDAQ: OPEN), Sotera Health Company (NASDAQ: SHC), and Cantaloupe,...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating FedEx, Opendoor, Sotera, and Cantaloupe and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FedEx Corp. (NYSE: FDX), Opendoor Technologies, Inc. (NASDAQ: OPEN), Sotera Health Company (NASDAQ: SHC), and Cantaloupe,...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating FedEx, Opendoor, Sotera, and Cantaloupe and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FedEx Corp. (NYSE: FDX), Opendoor Technologies, Inc. (NASDAQ: OPEN), Sotera Health Company (NASDAQ: SHC), and Cantaloupe,...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating GrafTech, Vintage Wine, Flowserve, and BRP and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GrafTech International Ltd. (NYSE: EAF), Vintage Wine Estates, Inc. (NASDAQ: VWE), Flowserve Corporation (NYSE: FLS), and...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating GrafTech, Vintage Wine, Flowserve, and BRP and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GrafTech International Ltd. (NYSE: EAF), Vintage Wine Estates, Inc. (NASDAQ: VWE), Flowserve Corporation (NYSE: FLS), and...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating GrafTech, Vintage Wine, Flowserve, and BRP and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GrafTech International Ltd. (NYSE: EAF), Vintage Wine Estates, Inc. (NASDAQ: VWE), Flowserve Corporation (NYSE: FLS), and...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating GrafTech, Vintage Wine, Flowserve, and BRP and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GrafTech International Ltd. (NYSE: EAF), Vintage Wine Estates, Inc. (NASDAQ: VWE), Flowserve Corporation (NYSE: FLS), and...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating Schmitt and Intuit and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Schmitt Industries, Inc. (NASDAQ: SMIT) and Intuit, Inc. (NASDAQ: INTU). Our investigations concern whether these companies...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Is Investigating Schmitt and Intuit and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Schmitt Industries, Inc. (NASDAQ: SMIT) and Intuit, Inc. (NASDAQ: INTU). Our investigations concern whether these companies...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Azure, Abbott, TuSimple, and Kohl’s and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Azure Power Global Limited (NYSE: AZRE), Abbott Laboratories (NYSE: ABT),...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Azure, Abbott, TuSimple, and Kohl’s and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Azure Power Global Limited (NYSE: AZRE), Abbott Laboratories (NYSE: ABT),...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Azure, Abbott, TuSimple, and Kohl’s and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Azure Power Global Limited (NYSE: AZRE), Abbott Laboratories (NYSE: ABT),...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Azure, Abbott, TuSimple, and Kohl’s and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Azure Power Global Limited (NYSE: AZRE), Abbott Laboratories (NYSE: ABT),...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Centessa and PayPal and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Centessa Pharmaceuticals Plc (NASDAQ: CNTA) and PayPal Holdings, Inc. (NASDAQ:...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Centessa and PayPal and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Centessa Pharmaceuticals Plc (NASDAQ: CNTA) and PayPal Holdings, Inc. (NASDAQ:...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lottery.com, NIO, Bed Bath & Beyond, and Dingdong and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lottery.com, Inc. (NASDAQ: LTRY, LTRYW), NIO, Inc. (NYSE: NIO), Bed Bath &...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lottery.com, NIO, Bed Bath & Beyond, and Dingdong and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lottery.com, Inc. (NASDAQ: LTRY, LTRYW), NIO, Inc. (NYSE: NIO), Bed Bath &...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lottery.com, NIO, Bed Bath & Beyond, and Dingdong and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lottery.com, Inc. (NASDAQ: LTRY, LTRYW), NIO, Inc. (NYSE: NIO), Bed Bath &...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lottery.com, NIO, Bed Bath & Beyond, and Dingdong and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lottery.com, Inc. (NASDAQ: LTRY, LTRYW), NIO, Inc. (NYSE: NIO), Bed Bath &...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lottery.com, NIO, Bed Bath & Beyond, and Dingdong and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Lottery.com, Inc. (NASDAQ: LTRY, LTRYW), NIO, Inc. (NYSE: NIO), Bed Bath &...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT), Palantir...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT), Palantir...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT), Palantir...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT), Palantir...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT), Palantir...
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Coupang, Humanigen, and Latch and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stitch Fix, Inc. (NASDAQ: SFIX), Coupang, Inc. (NYSE: CPNG), Humanigen, Inc....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Coupang, Humanigen, and Latch and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stitch Fix, Inc. (NASDAQ: SFIX), Coupang, Inc. (NYSE: CPNG), Humanigen, Inc....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Coupang, Humanigen, and Latch and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stitch Fix, Inc. (NASDAQ: SFIX), Coupang, Inc. (NYSE: CPNG), Humanigen, Inc....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch Fix, Coupang, Humanigen, and Latch and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stitch Fix, Inc. (NASDAQ: SFIX), Coupang, Inc. (NYSE: CPNG), Humanigen, Inc....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yatsen, Barclays, Warner Bros., and Olo and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Yatsen Holding Ltd. (NYSE: YSG), Barclays PLC (NYSE: BCS), Warner Bros....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yatsen, Barclays, Warner Bros., and Olo and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Yatsen Holding Ltd. (NYSE: YSG), Barclays PLC (NYSE: BCS), Warner Bros....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yatsen, Barclays, Warner Bros., and Olo and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Yatsen Holding Ltd. (NYSE: YSG), Barclays PLC (NYSE: BCS), Warner Bros....
Oct 06, 2022 21:00 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Yatsen, Barclays, Warner Bros., and Olo and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Yatsen Holding Ltd. (NYSE: YSG), Barclays PLC (NYSE: BCS), Warner Bros....
Oct 06, 2022 21:00 ET
Date of Virtual 2022 Annual Meeting of Stockholders Announced by Reading International
Reading International, Inc. (NASDAQ: RDI) announced today that Reading will hold its 2022 Annual Meeting of Stockholders (the “2022 Annual Meeting”) virtually through a web-based platform, commencing at 2:00 p.m. Eastern Time, on December 15, 2022....
Oct 06, 2022 21:00 ET
First Wave BioPharma, Inc. Announces Pricing of $6.0 Million Public Offering
First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases, today announced the...
Oct 06, 2022 21:00 ET
Satellos Bioscience Inc. Announces the Grant of Stock Options
Toronto, Ontario--(Newsfile Corp. - October 6, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a drug discovery company aimed at developing therapeutics that regenerate muscle as a new approach to treating disease conditions from muscular dystrophy to aging, announced today that its board of directors (the "Board") has approved grants of stock options (the "Stock Options") pursuant to the terms of the Company's Stock Option Plan. A total of 815,750 Stock Options have been awarded to directors, officers, employees and consultants of the Company. The Stock Options are exercisable at a price of $0.325 per share for a period of 10 years from the date of the grant.
Oct 06, 2022 20:30 ET
Alnylam Announces FDA Approval of Supplemental New Drug Application for OXLUMO® (lumasiran) in Advanced Primary Hyperoxaluria Type 1
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the U.S. Food and Drug Administration (FDA) approved a label expansion for OXLUMO® (lumasiran), an RNAi therapeutic administered via subcutaneous injection, now indicated for the treatment of primary hyperoxaluria type 1 (PH
Oct 06, 2022 20:00 ET
Power Nickel To Amend Technical Report
TORONTO, ON / ACCESSWIRE / October 6, 2022 / Power Nickel Inc. (the "Company" or "Power Nickel") (TSXV:PNPN)(OTCQB:CMETF)(Frankfurt:IVVI) announces that, as a result of a review by the staff of the British Columbia Securities Commission ("BCSC"), the Company is issuing the following news release to clarify disclosures regarding its Technical Report on the Nisk Project previously filed on SEDAR on August 30, 2022.
Oct 06, 2022 19:50 ET
Merck and Ridgeback Biotherapeutics Provide Update on New Clinical and Non-Clinical Studies of LAGEVRIO™ (molnupiravir)
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today issued the following announcement regarding data from two real-world evidence studies evaluating LAGEVRIO™ (molnupiravir), an investigational oral antiviral COVID-19 medicine. The first study, PANORAMIC, was conducted by the University of Oxford in the UK in highly-vaccinated adults mostly less than age 65 during the period when the circulating SARS-CoV-2 variant was predominantly Omicron. The second study, Clalit, was conducted by investigators in Israel in mostly older adults with underl
Oct 06, 2022 19:41 ET
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Against Olo Inc. (OLO)
The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Olo Inc. (NYSE: OLO) Class A common stock between August 11, 2021 and August 11, 2022, for violations of the Securities Exchange Act of 1934. Olo provides so
Oct 06, 2022 19:41 ET
TD Announces Non-Viability Contingent Capital AT1 Limited Recourse Capital Notes Issue
TORONTO, Oct. 6, 2022 /CNW/ - The Toronto-Dominion Bank ("TD") (TSX: TD) (NYSE: TD) today announced the pricing of a U.S. public offering of US$1.75 billion 8.125% Fixed Rate Reset Limited Recourse Capital Notes, Series 3 (Non-Viability Contingent Capital (NVCC)) (the "LRCNs"). The LRCNs will be registered with the U.S. Securities and Exchange Commission (the "SEC").
Oct 06, 2022 19:30 ET
Beasley Media Group Enters Into Exchange Agreement With Audacy
Beasley Media Group, LLC (Nasdaq: BBGI) (“Beasley” or the “Company”), a multi-platform media company, announced today that it entered into an asset exchange agreement with Audacy, Inc. (NYSE: AUD) whereby Beasley will exchange the radio station 720...
Oct 06, 2022 19:30 ET
Beasley Media Group Enters Into Exchange Agreement With Audacy
Beasley Media Group, LLC (Nasdaq: BBGI) (“Beasley” or the “Company”), a multi-platform media company, announced today that it entered into an asset exchange agreement with Audacy, Inc. (NYSE: AUD) whereby Beasley will exchange the radio station 720...
Oct 06, 2022 19:30 ET
BioNTech and Australia’s State of Victoria Form Strategic Partnership to Establish mRNA Research Center and Manufacturing Facility
BioNTech and Australia’s State of Victoria will establish an mRNA research and innovation center to strengthen translational research for innovative medicines from discovery to delivery As part of the partnership, BioNTech is committed to building a...

News Release Providers


Top